Ifom Ets - The Airc Institute Of Molecular Oncology

This study tested a new two-step strategy for patients with advanced colorectal cancer that had stopped responding to standard treatments. First, some patients received a chemotherapy drug (temozolomide) with the goal of making their tumors more vulnerable. If that happened, they…